Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
2
×
crispr
detroit blog main
detroit top stories
fda
gene editing
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
alector
alkermes
allogene therapeutics
amicus therapeutics
What
bio
crispr
2
×
new
roundup
allogene
biopharma
cancer
congress
congressional
diversity
executives
feud
group
hot
immunotherapy
investors
ipo
isn’t
juno
known
later
million
month
nearly
ny
pharma
remains
roster
shares
snapped
spectacles
splash
stay
testify
therapeutics
ticket
tuned
utero
vs
years
Language
Current search:
celgene
×
crispr
×
" raleigh-durham blog main "
×
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More